Alliance Pharma PLC (APH)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
45.70p
Buy
46.05p
0.10p (+0.22%)
Prices updated at 07 Jan 2025, 16:35 GMT
| Prices minimum 15 mins delay
Prices in GBX
Alliance Pharma PLC is a pharmaceutical products manufacturer. It distributes its products through wholesalers, retail pharmacies, hospitals and an international network of distributors.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2022 | 2023 |
---|---|---|
167m | 181m | |
102m | 105m | |
29m | 41m | |
17.20 | 22.59 | |
-21m | -33m | |
-8m | -29m | |
Sales, General and administrative | 64m | 54m |
Interest expenses | 5m | 10m |
Provision for income taxes | -2m | -16m |
Operating expenses | 73m | 64m |
Income before taxes | -23m | -49m |
Net income available to common shareholders | -21m | -33m |
0.0017 | -0.0613 | |
Net interest income | -5m | -10m |
Advertising and promotion | - | - |
Net investment income, net | 56,000 | -480,000 |
Realised capital gains (losses), net | - | - |
Total benefits, claims and expenses | - | - |
Earnings per share (diluted) | 0.0017 | -0.0613 |
Free cash flow per share | 0.0587 | 0.0531 |
Book value/share | 0.5499 | 0.5125 |
Debt equity ratio | 0.515835 | 0.53539 |
Balance sheet
Year | 2022 | 2023 |
---|---|---|
Current assets | 105m | 104m |
Current liabilities | 47m | 41m |
Total capital | 421m | 332m |
Total debt | 138m | 117m |
Total equity | 288m | 218m |
Total non current liabilities | - | - |
Loans | 134m | 114m |
Total assets | 537m | 415m |
Total liabilities | - | - |
Cash and cash equivalents | 32m | 22m |
Common stock | 540m | 540m |
Cash flow
Year | 2022 | 2023 |
---|---|---|
Cash at beginning of period | 29m | 32m |
Cash dividends paid | -9m | -10m |
20m | 31m | |
Investments (gains) losses | -17m | -918,000 |
32m | 22m | |
Net income | - | - |
21m | 31m | |
-607,000 | -696,000 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.